Patents by Inventor Peter Seres

Peter Seres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9822086
    Abstract: The invention relates to an improved process for the preparation of pharmaceutical active ingredients and also to high purity salts and pharmaceutical compositions prepared by said process. More particularly the invention relates to an economical process for the preparation of the compound having the international non-proprietary name (INN) vortioxetine and the chemical nomenclature 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine. Vortioxetine corresponds to the following Formula Still more particularly the invention relates to the preparation of high purity vortioxetine L-(+)-mandelate salt of the Formula IX, the conversion of this salt into other highly pure salts and also to the formulation of said salts.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: November 21, 2017
    Assignee: EGIS GYOGYSZERGYAR ZRT.
    Inventors: Istvan Ling, Gyorgy Jeges, Gyorgyi Kovanyine Lax, Balazs Volk, Peter Gregor, Jeno Peter Seres, Andras Dancso, Zoltan Varga, Eva Szabo
  • Publication number: 20170114034
    Abstract: The invention relates to an improved process for the preparation of pharmaceutical active ingredients and also to high purity salts and pharmaceutical compositions prepared by said process. More particularly the invention relates to an economical process for the preparation of the compound having the international non-proprietary name (INN) vortioxetine and the chemical nomenclature 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine. Vortioxetine corresponds to the following Formula Still more particularly the invention relates to the preparation of high purity vortioxetine L-(+)-mandelate salt of the Formula IX, the conversion of this salt into other highly pure salts and also to the formulation of said salts.
    Type: Application
    Filed: January 30, 2015
    Publication date: April 27, 2017
    Applicant: Egis Gyogyszergyar Zrt.
    Inventors: Istvan LING, Gyorgy JEGES, Gyorgyi KOVANYINE LAX, Balazs VOLK, Peter GREGOR, Jeno Peter SERES, Andras DANCSO, Zoltan VARGA, Eva SZABO
  • Patent number: 6800758
    Abstract: The invention relates to novel processes for the preparation of 5-chloro-4-{3-[N-[2-(3,4-dimethoxyphenyl)-ethyl]-N-methylamino]-propylamino-3(2H) pyridazinone of formula (I) and the pharmaceutically acceptable acid addition salts thereof. An important feature of the invention is using 3,4,5-trichloropyridazone as starting substance of the synthesis.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: October 5, 2004
    Assignee: Egis Gyogyszergyar Rt.
    Inventors: Peter Kótay Nagy, Gyula Simig, József Barkóczy, Ilona Sztruhár, László Balázs, Imre Domán, Zoltán Greff, Zoltán Rátkai, Peter Seres, Támas Karancsi
  • Publication number: 20040063969
    Abstract: A process is disclosed for the preparation of amorphous atorvastatin calcium which comprises dissolving crude atorvastatin calcium in a lower alkanol containing 2 to 4 carbon atoms or a mixture of such alkanols under heating and, after cooling, isolating the precipitated amorphous atorvastatin calcium.
    Type: Application
    Filed: October 20, 2003
    Publication date: April 1, 2004
    Applicant: EGIS GYOGYSZERGYAR RT.
    Inventors: Zoltan Greff, Peter Kotay Nagy, Jozsef Barkoczy, Gyula Simig, Laszlo Balazs, Imre Doman, Zoltan Ratkai, Peter Seres, Zsuzsa Szent Kirallyi, Ferenc Barta, Gyorgyi Vereczkeyne Donath, Kalman Nagy
  • Patent number: 6646133
    Abstract: The invention relates to a process for the preparation of amorphous atorvastatin calcium by recrystallization of crude atorvastatin from an organic solvent which comprises dissolving crude amorphous atorvastatin calcium in a lower alkanol containing 2-4 carbon atoms or a mixture of such alkanols under heating and isolating the amorphous atorvastatin calcium precipitated after cooling. The atorvastatin calcium obtained is a known valuable agent useful in treating hyperlipidemia and hypercholestrolemia.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: November 11, 2003
    Assignee: Egis Gyogyszergyar Rt.
    Inventors: Zoltan Greff, Peter Kotay Nagy, Jozsef Barkoczy, Gyula Simig, Laszlo Balazs, Imre Doman, Zoltan Ratkai, Peter Seres, Zsuzsa Szent Kirallyi, Ferenc Barta, Gyorgyi Vereczkeyne Donath, Kalman Nagy
  • Patent number: 6562810
    Abstract: The disclosure relates to a novel 8-substituted-9H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine compound of formula I and pharmaceutically acceptable quaternary ammonium salts thereof, a process for preparing the same, a pharmaceutical composition containing a 8-substituted-9H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine compound, and a method of treatment using the pharmaceutical composition. A complete description of the compound of formula I is found in the specification. The compounds of the general formula I possess unique competitive AMPA/kainite antagonist properties making them useful in the treatment of diseases where inhibition of the AMPA/kainite receptors may a favorable effect.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: May 13, 2003
    Assignee: Egis Gyogyszergyar RT.
    Inventors: László Balázs, József Barkóczy, Imre Domán, András Egyed, Istvän Gacsályi, Gábor Gigler, Zoltán Greff, István Gyertyán, Péter Kótay Nagy, Attila Kovács, György Lávay, Zoltán Rátkai, Péter Seres, Gyula Simig, Annamária Simó, Tamás Szabados, Géza Szabó, Károly Tihanyi, Miklós Végh, Géza Schneider, Judit Cselenyák
  • Patent number: 4906574
    Abstract: A fermenting device for culturing aerobic microorganisms equipped with a plurality of stirrer-agitators also includes a preferably conical baffle screen which is open at the top and the bottom and is spaced from the walls of the fermentor device, and is disposed between each agitator for guiding air dispersed by one agitator into the space under the next agitator for redispersion thereby. Suitably an annular guide member is disposed along the interior walls of the fermentor and under the baffle screen to improve the efficacy of the redispersion. The aerobic fermentation process involves the dispersing of air introduced into the fermentor by a rotated agitator and then conducting the dispersed air by a baffle screen and optional annular guide member to a next agitator for redispersion.
    Type: Grant
    Filed: June 10, 1988
    Date of Patent: March 6, 1990
    Assignee: Biogal Gyogyszergyar
    Inventors: Janos Erdei, Erno Karacsony, Laszlo Csermely, Jeno Szilagyi, Gyorgy Santha, Peter Seres